30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
The chances for an accident to occur are quite high when working with heavy machinery. Due to the si...
Read More >
In our previous client alert, we reported that certain key changes were introduced to the United Ara...
Read More >
Fir Tree Value Master Fund, L.P. v. Jarden Corp., No. 454, 2019 (Del. July 9, 2020) - Adding to its...
Read More >
This article is Part 2 of a two-article series. Part 1 discussed four main patterns of racial and ge...
Read More >
On June 20, 2019, New York lawmakers passed a pair of bills aimed at eliminating pay disparities bas...
Read More >
In a short published opinion filed September 13, 2019, the First District Court of Appeal (Div. 4) a...
Read More >